bpoc-thr(tbu)-oh cha
23631-92-7
|
ZL-Thr(tBu)-OSu
10068-65-2
|
h-thr(tbu)-pna
201807-08-1
|
z-thr(tbu)-otbu
14437-51-5
|
Z-Thr(tBu)-OH·DCHA
16966-07-7
|
FMOC-Thr(tBu)-Bt
1126433-39-3
|
Fmoc-Thr(tBu)-OPfp
117088-31-0
|
H-Thr(tBu)-OtBu.AcOH
5854-77-3
|
Z-Thr(tBu)-N2H2-Boc
41961-20-0
|
4-((Cyclohexylamino)methyl)benzoic acid hydrochloride
1158522-08-7
|
1-[(2,4-Dichlorophenyl)methyl]-N-(1,1-dimethylethyl)-2-methyl-1H-indole-3-methanamine
940364-43-2
|
Lopinavir impurity D [WHO-IP]
1989516-33-7
|
2-Methoxy-6-(pyrazol-1-yl)-benzonitrile
134104-43-1
|
1H-3-Benzazepin-7-ol, 8-chloro-2,3,4,5-tetrahydro-5-(3-iodophenyl)-3-methyl-, (S)-
131615-57-1
|
(4-Methyl-tetrahydro-furan-2-yl)-methanol
6906-52-1
|
N-(1-cyanocyclopentyl)-2-[4-(4-fluorobenzenesulfonyl)-1,4-diazepan-1-yl]acetamide
930439-75-1
|
4,5,6,7-Tetrahydrobenzo[d]isoxazole-3-carbaldehyde
1018584-77-4
|
tert-Butyl-DL-alanine
1375289-11-4
|
4-amino-N-[2-tert-butyl-1-(tetrahydro-2H-pyran-4-ylmethyl)-1H-benzimidazol-5-yl]-N-ethylbenzenesulfonamide
849349-65-1
|
